GB202212937D0 - Compounds and methods of use - Google Patents

Compounds and methods of use

Info

Publication number
GB202212937D0
GB202212937D0 GBGB2212937.3A GB202212937A GB202212937D0 GB 202212937 D0 GB202212937 D0 GB 202212937D0 GB 202212937 A GB202212937 A GB 202212937A GB 202212937 D0 GB202212937 D0 GB 202212937D0
Authority
GB
United Kingdom
Prior art keywords
compounds
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2212937.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edinburgh Molecular Imaging Ltd
Original Assignee
Edinburgh Molecular Imaging Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edinburgh Molecular Imaging Ltd filed Critical Edinburgh Molecular Imaging Ltd
Priority to GBGB2212937.3A priority Critical patent/GB202212937D0/en
Publication of GB202212937D0 publication Critical patent/GB202212937D0/en
Ceased legal-status Critical Current

Links

GBGB2212937.3A 2022-09-05 2022-09-05 Compounds and methods of use Ceased GB202212937D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2212937.3A GB202212937D0 (en) 2022-09-05 2022-09-05 Compounds and methods of use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2212937.3A GB202212937D0 (en) 2022-09-05 2022-09-05 Compounds and methods of use

Publications (1)

Publication Number Publication Date
GB202212937D0 true GB202212937D0 (en) 2022-10-19

Family

ID=83933296

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2212937.3A Ceased GB202212937D0 (en) 2022-09-05 2022-09-05 Compounds and methods of use

Country Status (1)

Country Link
GB (1) GB202212937D0 (en)

Similar Documents

Publication Publication Date Title
GB202019709D0 (en) Anti-Coronavirus antibodies and methods of use
IL288061A (en) Compounds and methods for the treatment of covid-19
EP4143196A4 (en) PI3K-a INHIBITORS AND METHODS OF USE THEREOF
IL292810A (en) Therapeutic compounds and methods of use
IL287768A (en) Kcnt1 inhibitors and methods of use
IL287751A (en) Kcnt1 inhibitors and methods of use
IL308835A (en) Substituted indole compounds and methods of use thereof
SG11202112277PA (en) Acss2 inhibitors and methods of use thereof
EP4125831A4 (en) Kcnt1 inhibitors and methods of use
IL299245A (en) Lair-1-binding agents and methods of use thereof
IL304680A (en) Urolithin derivatives and methods of use thereof
IL286697A (en) Neuregulin-4 compounds and methods of use
IL305933A (en) Indazole based compounds and associated methods of use
IL311038A (en) Indole compounds and methods of use
IL289649A (en) Formulations of rbp4 inhibitors and methods of use
IL299704A (en) Tetrahydropyrazolo-pyrazinyl-dihydroimidazolone or tetrahydropyrazolo-pyridinyl-dihydroimidazolone compounds and methods of using same
GB202319843D0 (en) CAS13-based compositions and methods of use thereof
IL264854A (en) Spt5 inhibitors and methods of use thereof
EP4142740A4 (en) Compositions and methods of use thereof
IL299700A (en) Kcnt1 inhibitors and methods of use
IL299163A (en) Macrocyclic compounds and methods of use thereof
GB202315697D0 (en) Compounds and methods of use
EP4110317A4 (en) Kcnt1 inhibitors and methods of use
GB202212937D0 (en) Compounds and methods of use
GB2589398B (en) Compounds and methods of use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)